Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data
- PMID: 32079150
- PMCID: PMC7074197
- DOI: 10.3390/jcm9020538
Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data
Abstract
The geographic spread of 2019 novel coronavirus (COVID-19) infections from the epicenter of Wuhan, China, has provided an opportunity to study the natural history of the recently emerged virus. Using publicly available event-date data from the ongoing epidemic, the present study investigated the incubation period and other time intervals that govern the epidemiological dynamics of COVID-19 infections. Our results show that the incubation period falls within the range of 2-14 days with 95% confidence and has a mean of around 5 days when approximated using the best-fit lognormal distribution. The mean time from illness onset to hospital admission (for treatment and/or isolation) was estimated at 3-4 days without truncation and at 5-9 days when right truncated. Based on the 95th percentile estimate of the incubation period, we recommend that the length of quarantine should be at least 14 days. The median time delay of 13 days from illness onset to death (17 days with right truncation) should be considered when estimating the COVID-19 case fatality risk.
Keywords: distribution; emerging infectious diseases; epidemiology; incubation period; virus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- National Health Commission of the People’s Republic of China Update on Pneumonia of New Coronavirus Infection as of 21:00 on January 31. [(accessed on 1 February 2020)]; Available online: http://www.nhc.gov.cn/xcs/yqtb/202002/84faf71e096446fdb1ae44939ba5c528.s....
-
- European Centre for Disease Prevention and Control data Geographical Distribution of 2019-nCov Cases. [(accessed on 24 January 2020)]; Available online: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.
Grants and funding
- JP18fk0108050/Japan Agency for Medical Research and Development
- H.N.: 17H04701, 17H05808, 18H04895 and 19H01074; R.K.: 18J21587/Japan Society for the Promotion of Science
- NA/Inamori Foundation
- JPMJCR1413/Core Research for Evolutional Science and Technology
- NA/Ministry of Education, Culture, Sports, Science and Technology
LinkOut - more resources
Full Text Sources
Medical